MAPK1 and esophageal squamous cell carcinoma: Specifically, lnc191 interacts with GRP78 and facilitates the phosphorylation activity of EGFR at the Y845 site, thereby activating the p‐EGFR/p‐ERK signaling pathway and accelerating ESCC progression.